Skip to main navigation
Intellia Therapeutics home page
  • Home
  • About
    • Who We Are
    • Core Values
    • Leadership
    • Partners
  • Our Science
    • What is CRISPR?
    • CRISPR Videos
    • Scientific Publications & Presentations
    • Glossary
  • Programs & Pipeline
  • Patient Focus
    • Disease Focus
    • Patient Stories
  • Investors & Media
    • Overview
    • Press Releases
    • Scientific Publications & Presentations
    • Corporate Presentation
    • Events
    • Press Kit
    • Corporate Governance
    • Financial Info
    • Analyst Coverage
    • Investor Resources
  • Careers
    • Life @ Intellia
    • Join Us
  • Contact
menu
Intellia Therapeutics Head office building

SEC Filing
Details

investor relations

  • Overview
  • Press Releases
  • Scientific Publications & Presentations
  • Corporate Presentation
  • Events
  • Press Kit
  • Corporate Governance
  • Financial Info
  • Analyst Coverage
  • Investor Resources

Document Details

Form
10-Q
Filing Date
Aug 1, 2018
Document Date
Jun 30, 2018
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Intellia Therapeutics
Issuer
Intellia Therapeutics, Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.INS - XBRL INSTANCE DOCUMENT
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE

Quick
Links

RSS FEEDS
EMAIL ALERTS
PRINT PAGE

Footer Legal

  • Cookie Policy
  • Terms of Use
  • Privacy Policy
© 2026. Intellia Therapeutics, Inc.

Intellia Therapeutics and the Intellia Therapeutics logo are registred trademarks with the U.S. Patent & Trademark Offce.